New epilepsy treatment offers 'on demand' seizure suppression

May 27, 2014, University College London
Generalized 3 Hz spike and wave discharges in a child with childhood absence epilepsy. Credit: Wikipedia.

A new treatment for drug-resistant epilepsy with the potential to suppress seizures 'on demand' with a pill, similar to how you might take painkillers when you feel a headache coming on, has been developed by UCL (University College London) researchers funded by the Wellcome Trust.

The treatment, described in Nature Communications, combines genetic and chemical approaches to suppress seizures without disrupting normal brain function. The technique was demonstrated in rodents but in future we could see people controlling seizures on-demand with a simple pill.

Epilepsy affects around 50 million people worldwide including 600,000 in the UK and around a quarter of cases are resistant to conventional treatments. Many of these cases could be addressed by the new treatment method, which relies on genetic modification of to make them sensitive to a normally inactive compound.

"First, we inject a modified virus into the area of the brain where seizures arise," explains Professor Dimitri Kullmann of the UCL Institute of Neurology, senior author of the research. "This virus instructs the brain cells to make a protein that is activated by CNO (clozapine-N-oxide), a compound that can be taken as a pill. The activated protein then suppresses the over-excitable brain cells that trigger seizures, but only in the presence of CNO.

"At the moment, severe seizures are treated with drugs that suppress the excitability of all brain cells, and patients therefore experience side effects. Sometimes the dose required to stop seizures is so high that patients need to be sedated and taken to intensive care. If we can take our new method into the clinic, which we hope to do within the next decade, we could treat patients who are susceptible to severe seizures with a one-off injection of the modified virus, and then use CNO only when needed.

"CNO would be given as a pill in the event that patients could predict when seizures were likely to occur. For example, many people with treatment-resistant epilepsy experience clusters of seizures, where severe seizures are preceded by smaller ones. Seizure risk is also high when people are ill, sleep deprived, or at certain times of the menstrual cycle, so these would all be good times to take the pill as a preventative measure. In urgent situations, the compound could be given as an injection. We could even consider a fully automatic delivery system, where CNO was given by a pump, as is done for insulin in some people with diabetes."

As CNO has a half-life of about a few hours and only affects the pre-treated epileptic parts of the brain, the new method avoids the need to permanently alter the brain or treat the whole brain with seizure-suppressing drugs. It builds on similar work by Professor Kullmann's group using gene therapy to 'calm down' brain cells, or using light pulses to activate seizure-suppressing receptors in the brain. The new technique works in a similar way but is reversible and avoids the need for invasive devices to deliver light to the brain.

"After the one-off injection into affected areas of the brain, our new technique would require nothing beyond CNO, administered as an injection or a pill, to suppress seizures when required," says Professor Kullmann. "This makes it more attractive than alternative forms of targeted therapy such as surgery to remove the brain region where seizures arise, or gene therapy that permanently alters the excitability of brain cells.

"Although there is currently no evidence that permanently suppressing excitability in a small area affects function, we cannot be sure that it would have no impact long-term. Our new method is completely reversible, so if there were any side-effects then people could simply stop taking the CNO pill."

Dr John Williams, head of clinical activities, neuroscience and mental health at the Wellcome Trust said: "Epilepsy is a debilitating condition with limited treatment options available to the 50 million people affected globally. We look forward to seeing how this innovative approach for targeted control of seizure activity might translate into new treatments options for managing and controlling in humans."

Explore further: A single switch dictates severity of epileptic seizures, researchers find

More information: Kätzel, Nicholson, Schorge, Walker, Kullmann, Chemical-genetic attenuation of focal neocortical seizures, Nature Communications: dx.doi.org/10.1038/NCOMMS4847

Related Stories

A single switch dictates severity of epileptic seizures, researchers find

April 14, 2014
A switch in the brain of people with epilepsy dictates whether their seizures will be relatively mild or lead to a dangerous and debilitating loss of consciousness, Yale researchers have found.

Can epileptic seizures be prevented or predicted?

March 31, 2014
A biomedical engineering professor at the Institute of Biomaterials & Biomedical Engineering (IBBME) and the Edward S. Rogers Sr. Department of Electrical & Computer Engineering (ECE), Bardakjian works with a team of neurological ...

Task force issues improved definition for epilepsy

May 6, 2014
A UCLA neurosurgeon was part of a prestigious task force that has created a new clinical definition for epilepsy. The new interpretation, which updates a definition that had been in use for nearly a decade, broadens the scope ...

Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy

April 22, 2014
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians ...

Sleep deprivation found to trigger initial seizure 

May 16, 2014
Neurologists studying WA's first-ever seizure database have established that sleep deprivation is more likely to act as a trigger for people having seizures, rather than a provoked cause of epilepsy.

Brain study uncovers vital clue in bid to beat epilepsy

September 3, 2013
People with epilepsy could be helped by new research into the way a key molecule controls brain activity during a seizure.

Recommended for you

Brain zaps may help curb tics of Tourette syndrome

January 16, 2018
Electric zaps can help rewire the brains of Tourette syndrome patients, effectively reducing their uncontrollable vocal and motor tics, a new study shows.

A 'touching sight': How babies' brains process touch builds foundations for learning

January 16, 2018
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.

Researchers identify protein involved in cocaine addiction

January 16, 2018
Mount Sinai researchers have identified a protein produced by the immune system—granulocyte-colony stimulating factor (G-CSF)—that could be responsible for the development of cocaine addiction.

Neuroscientists suggest a model for how we gain volitional control of what we hold in our minds

January 16, 2018
Working memory is a sort of "mental sketchpad" that allows you to accomplish everyday tasks such as calling in your hungry family's takeout order and finding the bathroom you were just told "will be the third door on the ...

Brain imaging predicts language learning in deaf children

January 15, 2018
In a new international collaborative study between The Chinese University of Hong Kong and Ann & Robert H. Lurie Children's Hospital of Chicago, researchers created a machine learning algorithm that uses brain scans to predict ...

Preterm babies may suffer setbacks in auditory brain development, speech

January 15, 2018
Preterm babies born early in the third trimester of pregnancy are likely to experience delays in the development of the auditory cortex, a brain region essential to hearing and understanding sound, a new study reveals. Such ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.